Skip to content

Clarithromycin 13C,D3

Clarithromycin 13C,D3

Product Description
CAT No.
ALN-C040D01
CAS No.
NA
Mol. F.
C3713CH66D3NO13
Mol. Wt.
752
Stock
Please Inquire
Chemical Name : (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-6-(((2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methyl(methyl-13C-d3)amino)tetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
Smiles : O=C([C@H](C)[C@@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@H](C)[C@@H](O[C@H]2[C@H](O)[C@@H](N(C)[13C]([2H])([2H])[2H])C[C@@H](C)O2)[C@](C)(OC)C[C@H]3C)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C3=O
Inchi : InChI=1/C42H67F2N3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-26-38(43)31-39-29-36(32-45-39)34-47(2)35-37-30-42(46-33-37)40-27-24-25-28-41(40)44/h24-25,27-30,32-33,38,45-46H,3-23,26,31,34-35H2,1-2H3

Stability indicating HPLC-ECD method for the analysis of clarithromycin in pharmaceutical dosage forms: method scaling versus re-validation

By Makoni, Pedzisai A.; Chikukwa, Mellisa T. R.; Khamanga, Sandile M. M.; Walker, Roderick B.nFrom Scientia Pharmaceutica (2019), 87(4), 31

Stability indicating Rp-Hplc method development and validation for the simultaneous estimation of gemcitabine and clarithromycin in bulk and pharmaceutical dosage form

By Kumar, Y. Anil; Sirisha, Y.; Harini, A. L.; Prathyusha, A. – From World Journal of Pharmaceutical Research (2018), 7(8Spec.Iss.), 1-8

Request For Quotation